Van ECK Associates Corp acquired a new position in Azenta, Inc. (NASDAQ:AZTA – Get Rating) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,074 shares of the company's stock, valued at approximately $46,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Glassman Wealth Services purchased a new stake in Azenta in the second quarter worth about $25,000. Quadrant Capital Group LLC purchased a new stake in Azenta in the second quarter worth about $26,000. Wipfli Financial Advisors LLC purchased a new stake in Azenta in the third quarter worth about $32,000. Castle Wealth Management LLC purchased a new stake in Azenta in the second quarter worth about $34,000. Finally, Assetmark Inc. purchased a new stake in Azenta in the second quarter worth about $39,000. 96.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AZTA has been the subject of several recent research reports. Needham & Company LLC lifted their target price on shares of Azenta from $74.00 to $78.00 and gave the company a "buy" rating in a report on Tuesday, November 15th. TheStreet upgraded shares of Azenta from a "d+" rating to a "c-" rating in a report on Tuesday, December 13th. KeyCorp lowered their target price on shares of Azenta from $90.00 to $70.00 and set an "overweight" rating for the company in a report on Monday, October 24th. Finally, Stephens lifted their target price on shares of Azenta from $60.00 to $65.00 in a report on Thursday, November 17th. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, Azenta currently has an average rating of "Buy" and an average target price of $72.60.

Azenta Stock Down 1.4 %

Azenta (NASDAQ:AZTA – Get Rating) last announced its quarterly earnings results on Monday, November 14th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.10. The company had revenue of $137.57 million during the quarter, compared to the consensus estimate of $132.01 million. Azenta had a net margin of 383.23% and a return on equity of 1.31%. On average, sell-side analysts expect that Azenta, Inc. will post 0.33 EPS for the current year.

Azenta Company Profile

(Get Rating)

Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.

Read More

• Get a free copy of the StockNews.com research report on Azenta (AZTA)
• MarketBeat Week in Review – 1/16 – 1/20
• Does Old Dominion Show That Trucking Is Hitting The Brakes?
• Nordstrom Puts Fear Of Markdowns Into Retail Sector
• Exxon Mobil Stock: Within Striking Distance Of Buy Point
• High-Dividend-Yielding BHP Sees China Driving '23 Growth

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.